Coloplast A/S (OTCMKTS:CLPBY) Sees Strong Trading Volume Following Analyst Upgrade

Shares of Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) saw unusually-high trading volume on Thursday after Sanford C. Bernstein upgraded the stock to a hold rating. 1,386,759 shares traded hands during trading, an increase of 241% from the previous session’s volume of 407,150 shares.The stock last traded at $8.60 and had previously closed at $8.48.

Coloplast A/S Stock Up 1.4%

The company’s 50 day moving average price is $8.74 and its two-hundred day moving average price is $9.13. The company has a current ratio of 1.61, a quick ratio of 1.00 and a debt-to-equity ratio of 1.20. The firm has a market cap of $19.38 billion, a PE ratio of 35.83, a PEG ratio of 0.81 and a beta of 0.26.

Coloplast A/S (OTCMKTS:CLPBY) last announced its earnings results on Tuesday, November 4th. The company reported $0.07 EPS for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.02). The company had revenue of $1.07 billion during the quarter, compared to the consensus estimate of $1.10 billion. Coloplast A/S had a return on equity of 24.99% and a net margin of 13.01%. On average, equities research analysts expect that Coloplast A/S Sponsored ADR will post 0.31 EPS for the current fiscal year.

About Coloplast A/S

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.